In a heterogeneous group of subjects, GrK was more abundant in brain CD103–CD69+CD8+ T cells than CD103+CD69+CD8+ cells populations, but most brain donors had no neurological disease or were patients with MS or Parkinson’s diseases and no data could be correlated with AD16. This evidence concerns the gene CD8A and myeloid sarcoma.